2014, № 12 (173)

1. Gorustovich, J. Features of the early neonatal period in children born as a result of IVF / J. Gorustovich, T.N. Wojtowicz, S.E. Efymenko // Medical News. — 2014. — №2 (233). — P. 62–64.

2. Katargina, L.A. Current status of retinopathy of prematurity and objectives for improving eye care for premature babies in the Russian Federation / L.A. Katargina // Retinopathy of Prematurity: Coll. scientific. works. — M., 2011 — P. 5–10.

3. Krasil'nikova, V.L. The use of angiogenesis inhibitors in treatment of the back of an aggressive form of retinopathy of prematurity / V.L. Krasil'nikova, K.U. Vilchuk, I.N. Smirnov // Ophthalmology Eastern Europe. — 2012. — №3. — P. 53–56.

4. Molchanova, E.V. Features state of the vision of children born through in vitro fertilization and embryo transfer / E.V. Molchanova // Russian pediatric ophthalmology. — 2007. — №4. — P. 31–34

5. Health of children born after IVF / G.M. Savelieva [et al.] // Obstetrics and gynecology. — 2010. — №5. — P. 49–54.

6. Risk factors and frequency of retinopathy in very preterm children in the use of modern perinatal technologies / E.I. Sidorenko [et al.] // Russian children ophthalmology. — 2012. — №3. — P. 5–9.

7. Analysis of the retinal vessels in the prediction of the flow of retinopathy of prematurity / A.V. Tereshchenko [et al.] // Ophthalmosurgery. — 2006. — 8. — №3. — P. 41–44.

8. Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity Revisited // Int. Arch. Ophthalmol. — 2005. — Vol. 123. — No. 7. — P. 991–999.

9. Lad, E.M. Incidence of Retinopathy of Prematurity in the United States: 1997 through 2005 / E.M. Lad, T. Hernandez-Boussard, J.M. Morton // Am. J. Ophthalmol. — 2009, Sep. — V.148. — №3. — P. 451–458.

10. Lee, J. Perinatal infection, inflammation, and retinopathy of prematurity / J. Lee, O. Dammann // Semin. Fetal. Neonatal. Med. — Feb., 2012. — V.17(1). — P. 26–29.

11. Micieli, J.A. A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurity / J.A. Micieli, M. Surkont, A.F. Smith // Am. J. Ophthalmol. — 2009. — V.148. — №4. — P. 536–543.

12. Mintz-Hittner, Helen A. Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity / Helen A. Mintz-Hittner, Kathleen A. Kennedy, Alice Z. Chuang // N. Engl. J. Med. — 2011. — №364. — P. 603–615.

13. Vascular endothelial growth factor in eye disease / J.S. Penn [et al.] // Prog. Retin. Eye Res. — 2008. — №27. — P. 331–371.

14. Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life / P. Sapieha [et al.] // J. Clin. Invest. — 2010. — V.120. — №9. — P. 3022–3032.

15. Semenza, G.L. Hydroxylation of HIF-1: oxygen sensing at the molecular level / G.L. Semenza // Physiology (Bethesda). — 2004. — №19. — P. 176–182.

16. West, H. Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytes / H. West, W.D. Richardson, M. Fruttiger // Development. — 2005. — №132. — P. 1855–1862.

About this article